228 related articles for article (PubMed ID: 27609205)
1. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
[TBL] [Abstract][Full Text] [Related]
3. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.
Moga DC; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D
Drugs Aging; 2017 Jan; 34(1):55-65. PubMed ID: 27896799
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2014; 41(4):1223-8. PubMed ID: 24787914
[TBL] [Abstract][Full Text] [Related]
7. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
[TBL] [Abstract][Full Text] [Related]
8. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
[TBL] [Abstract][Full Text] [Related]
10. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
[TBL] [Abstract][Full Text] [Related]
11. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
[TBL] [Abstract][Full Text] [Related]
12. Change in psychotropic drug use among community-dwelling people aged 75 years and older in Finland: repeated cross-sectional population studies.
Desplenter F; Caenen C; Meelberghs J; Hartikainen S; Sulkava R; Bell JS
Int Psychogeriatr; 2011 Oct; 23(8):1278-84. PubMed ID: 21554797
[TBL] [Abstract][Full Text] [Related]
13. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
[TBL] [Abstract][Full Text] [Related]
14. Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland.
Bell JS; Lönnroos E; Koivisto AM; Lavikainen P; Laitinen ML; Soininen H; Hartikainen S
J Alzheimers Dis; 2011; 26(2):231-7. PubMed ID: 21593561
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
Tiihonen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 52(1):127-32. PubMed ID: 26967224
[TBL] [Abstract][Full Text] [Related]
16. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
[TBL] [Abstract][Full Text] [Related]
17. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Clin Psychopharmacol; 2014 Aug; 34(4):435-40. PubMed ID: 24875073
[TBL] [Abstract][Full Text] [Related]
19. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2018; 64(2):437-445. PubMed ID: 29914029
[TBL] [Abstract][Full Text] [Related]
20. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
